Cargando…

Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

Detalles Bibliográficos
Autores principales:	Añón, José M., Villar, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778474/ https://www.ncbi.nlm.nih.gov/pubmed/33388793 http://dx.doi.org/10.1007/s00134-020-06330-w

Ejemplares similares

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply
por: Meduri, G. Umberto, et al.
Publicado: (2021)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
por: Arabi, Yaseen M., et al.
Publicado: (2020)

Corticosteroids for COVID-19: the search for an optimum duration of therapy
por: Mishra, Gyanshankar P, et al.
Publicado: (2021)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease
por: Taboada, Manuel, et al.
Publicado: (2020)

Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020)

Caution When Comparing the Impact of Corticosteroids in COVID-19
por: Confalonieri, Marco, et al.
Publicado: (2021)

Does melatonin reduce mortality in COVID-19?
por: Pilia, Eros, et al.
Publicado: (2022)

Extracorporeal Membrane Oxygenation Transport for Severe COVID-19: Why We Can and Should!
por: Mang, Sebastian, et al.
Publicado: (2022)

Ten Reasons Why Abdominal Bandages Should Not Be Used after Labor
por: Conway, W. B.
Publicado: (1893)

When to call it off: Defining the role of low-dose corticosteroids in thwarting the progression of non-severe COVID-19
por: Almas, Talal, et al.
Publicado: (2021)

Early prone position for COVID-19 patients with severe hypoxia: reduces the mortality but increases the intubation risk?
por: Gulart, Aline Almeida, et al.
Publicado: (2020)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled therapy reduces COPD mortality
por: Andreas, Stefan, et al.
Publicado: (2020)

Why cannot Taiwan be COVID-19 free?
por: Jang, Tyng-Yuan
Publicado: (2022)

Reduced mortality in New Zealand during the COVID-19 pandemic
por: Kung, Stacey, et al.
Publicado: (2021)

Heterotopic ossification and COVID 19: Imaging analysis of ten consecutive cases
por: Mezghani, Sarah, et al.
Publicado: (2022)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Why the United States failed to contain COVID‐19
por: Nowroozpoor, Armin, et al.
Publicado: (2020)

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: López-Campos, José Luis, et al.
Publicado: (2021)

Ten reasons why a sequence-based nomenclature is not useful for fungi anytime soon
por: Thines, Marco, et al.
Publicado: (2018)

Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
por: Liu, Wang-Da, et al.
Publicado: (2022)

Adjunctive corticosteroid treatment for organizing pneumonia in COVID-19 patients with persistent respiratory failure
por: Segala, Francesco Vladimiro, et al.
Publicado: (2021)

Effects of corticosteroids on severe community-acquired pneumonia: a closer look at the evidence
por: Chiang, Cho-Han, et al.
Publicado: (2023)

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?
por: Ayerbe, Luis, et al.
Publicado: (2021)

Why the application of IVIG might be beneficial in patients with COVID-19
por: Kindgen-Milles, Detlef, et al.
Publicado: (2022)

Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19?
por: Nayak, Saurabh, et al.
Publicado: (2021)

COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Erratum: COVID-19–related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids
por: Peters, Michael C.
Publicado: (2020)

Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients
por: Harutyunyan, Gurgen, et al.
Publicado: (2022)

55 Risk of Sepsis and Mortality in SJS and TENS Patients Treated with Corticosteroids
por: Everett, Catherine, et al.
Publicado: (2023)

Why we should not recommend or offer fluvoxamine to COVID-19 patients?
por: Trkulja, Vladimir
Publicado: (2022)

Prone positioning might reduce the need for intubation in people with severe COVID-19
por: McGuire, W Cameron, et al.
Publicado: (2021)

Ten Letters, with Answers
Publicado: (1873)

Comments on Air Pollutant Exposures and COVID-19 Severity and Mortality: Some Concerns on Methodology
por: Chen, Hui-Yuan, et al.
Publicado: (2022)

Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)

The Reason Why
por: Molyneaux, Grant
Publicado: (1895)

The Reason Why
Publicado: (1887)

The Reason Why
por: Swan, Samuel
Publicado: (1891)

Travel during COVID-19 pandemic in Libya: reasons of travel, disease importation and travel regulations
por: Ramadan, Ahmad M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3dpb56pbnlakt0seo4b7qa731b